Clinical trial
Multicenter, Evaluator-Blinded, Randomized, No-Treatment Controlled Study of the Effectiveness and Safety of JUVÉDERM® VOLITE™ Injectable Gel for the Improvement in Skin Quality
NCT06547125 is registered in ClinicalTrials.gov with AbbVie as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Multicenter, Evaluator-Blinded, Randomized, No-Treatment Controlled Study of the Effectiveness and Safety of JUVÉDERM® VOLITE™ Injectable Gel for the Improvement in Skin Quality
- Lead sponsor
- AbbVie
- Phase
- Phase 2/3
- Overall status
- Completed
- Start date
- July 18, 2024
- Completion date
- February 5, 2026
- Enrollment
- 135 (actual)
- Sites
- 6
Conditions
As the registry lists them; a condition with its own page is linked.
skin quality deficit